Xtx Topco LTD Aprea Therapeutics, Inc. Transaction History

Xtx Topco LTD

  • $710 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$1.59 - $3.16 $43,383 - $86,220
-27,285 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$2.87 - $5.58 $78,307 - $152,250
27,285 New
27,285 $78,000

Others Institutions Holding APRE

# of Institutions
3
Shares Held
999
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email